We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
+18.3%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
AUM
$5.16B
AUM Growth
+$674M
Cap. Flow
-$94.1M
Cap. Flow %
-1.83%
Top 10 Hldgs %
86.5%
Holding
54
New
20
Increased
7
Reduced
4
Closed
1

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 64.51%
2 Consumer Staples 8.63%
3 Communication Services 7.91%
4 Financials 7.45%
5 Healthcare 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
26
Charles Schwab
SCHW
$187B
$11.7M 0.23%
+286,882
New +$11.8M
CCJ icon
27
Cameco
CCJ
$42.4B
$11.4M 0.22%
1,025,700
TBPH icon
28
Theravance Biopharma
TBPH
$877M
$11.2M 0.22%
304,256
AMZN icon
29
Amazon
AMZN
$2.96T
$10.3M 0.2%
+231,240
New +$9.64M
BRK.A icon
30
Berkshire Hathaway Class A
BRK.A
$1.12T
$9.99M 0.19%
+40
New +$10M
VRSN icon
31
VeriSign
VRSN
$26.6B
$9.16M 0.18%
+105,154
New +$8.74M
LBTYK icon
32
Liberty Global Class C
LBTYK
$3.49B
$8.71M 0.17%
+248,697
New +$8.57M
NBRV
33
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8.24M 0.16%
2,748
-52
-2% -$126K
V icon
34
Visa
V
$677B
$8.19M 0.16%
+92,100
New +$7.92M
MCO icon
35
Moody's
MCO
$82.7B
$8.06M 0.16%
+71,949
New +$7.72M
SPGI icon
36
S&P Global
SPGI
$120B
$7.61M 0.15%
+58,187
New +$7.23M
TIG
37
DELISTED
TiGenix American Depositary Shares
TIG
$7.55M 0.15%
483,870
CLSD
38
DELISTED
Clearside Biomedical
CLSD
$6.79M 0.13%
56,993
+16,993
+42% +$2.01M
KA
39
DELISTED
Kineta, Inc. Common Stock
KA
$6.77M 0.13%
6,185
ADAP
40
DELISTED
Adaptimmune Therapeutics
ADAP
$6.56M 0.13%
+1,190,476
New +$5.21M
ACIU icon
41
AC Immune
ACIU
$240M
$5.7M 0.11%
550,000
SFUN
42
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$4.89M 0.09%
30,000
IDXX icon
43
Idexx Laboratories
IDXX
$46.2B
$4.46M 0.09%
+28,825
New +$3.97M
PRTA icon
44
Prothena Corp
PRTA
$450M
$4.18M 0.08%
75,000
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.77M 0.07%
+725,000
New +$3.97M
JNCE
46
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.75M 0.07%
+170,300
New +$3.61M
SNDX icon
47
Syndax Pharmaceuticals
SNDX
$1.82B
$3.37M 0.07%
+245,449
New +$2.55M
PYPL icon
48
PayPal
PYPL
$50.5B
$3.23M 0.06%
75,186
XNET
49
Xunlei
XNET
$326M
$1.63M 0.03%
403,041
BABA icon
50
Alibaba
BABA
$308B
$999K 0.02%
9,262

Similar funds

Hillhouse Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Hillhouse Investment Management held 54 positions worth $5.16B, up 15% from $4.48B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Hillhouse Investment Management's Q1 2017 filing shows 20 new, 7 increased, 4 reduced and 1 closed positions. Its largest new stake was TripAdvisor: 1,394,066 shares worth $60.2M. The largest sale was JD.com, an estimated $532M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 65% of assets, down from 66% a quarter earlier, followed by Consumer Staples and Communication Services.

  • Hillhouse Investment Management's largest Q1 2017 buy was TripAdvisor: 1,394,066 shares worth $60.2M.
  • Hillhouse Investment Management added most to Booking.com in Q1 2017, an estimated $110M increase.
  • Hillhouse Investment Management's biggest Q1 2017 reduction was JD.com, cutting an estimated $532M.
  • Hillhouse Investment Management fully exited ZTO Express in Q1 2017, selling an estimated $12.1M.
  • Hillhouse Investment Management's ten largest holdings make up 87% of its $5.16B portfolio in Q1 2017.
  • Hillhouse Investment Management opened 20 new positions and closed 1 in Q1 2017.
  • Hillhouse Investment Management's portfolio value rose 15% quarter-over-quarter to $5.16B.

Based on Hillhouse Investment Management's 13F filing for Q1 2017, filed 15 May 2017.